Loomis, Sayles & Company’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-161,749
Closed -$4.84M 698
2019
Q1
$4.84M Sell
161,749
-188,520
-54% -$5.4M 0.01% 437
2018
Q4
$10.8M Sell
350,269
-14,193
-4% -$518K 0.03% 300
2018
Q3
$13.8M Buy
364,462
+11,678
+3% +$442K 0.03% 299
2018
Q2
$13.5M Sell
352,784
-250,737
-42% -$8.45M 0.03% 341
2018
Q1
$20.4M Buy
603,521
+4,493
+0.8% +$172K 0.04% 238
2017
Q4
$26.6M Buy
599,028
+178,372
+42% +$8.13M 0.06% 196
2017
Q3
$21.1M Buy
420,656
+167,546
+66% +$8.56M 0.05% 266
2017
Q2
$13.4M Sell
253,110
-28,715
-10% -$1.54M 0.03% 352
2017
Q1
$15.7M Sell
281,825
-8,787
-3% -$485K 0.04% 322
2016
Q4
$15.1M Sell
290,612
-52,001
-15% -$2.51M 0.04% 339
2016
Q3
$16.5M Buy
342,613
+5,984
+2% +$303K 0.04% 317
2016
Q2
$18.6M Sell
336,629
-52,189
-13% -$2.87M 0.05% 290
2016
Q1
$20.8M Sell
388,818
-103,677
-21% -$5.11M 0.06% 252
2015
Q4
$25.4M Sell
492,495
-340,202
-41% -$16.9M 0.07% 214
2015
Q3
$37.6M Sell
832,697
-10,212
-1% -$482K 0.11% 142
2015
Q2
$39M Sell
842,909
-148
-0% -$6.48K 0.11% 164
2015
Q1
$36.2M Sell
843,057
-4,176
-0.5% -$159K 0.1% 175
2014
Q4
$29.4M Sell
847,233
-1,036
-0.1% -$34.4K 0.08% 216
2014
Q3
$27.5M Sell
848,269
-40,048
-5% -$1.34M 0.08% 219
2014
Q2
$30.1M Buy
888,317
+169,814
+24% +$5.44M 0.09% 220
2014
Q1
$19.6M Sell
718,503
-22,854
-3% -$679K 0.06% 352
2013
Q4
$26.5M Sell
741,357
-5,942
-0.8% -$197K 0.08% 247
2013
Q3
$22.5M Sell
747,299
-11,609
-2% -$380K 0.07% 285
2013
Q2
$22.1K Buy
+758,908
New +$21.4M 0.08% 262

Other funds holding PBH

Loomis, Sayles & Company's PBH Position: Q2 2019 in Review

Loomis, Sayles & Company sold out of Prestige Consumer Healthcare (PBH) in Q2 2019, closing a stake of 161,749 shares — an estimated $4.84M sold.

Loomis, Sayles & Company first reported a position in PBH in Q2 2013 and held it in 24 quarters. The position peaked at $39M in Q2 2015. 212 funds tracked by Wall St. Rank hold PBH as of Q2 2019.

  • Loomis, Sayles & Company reported no remaining Prestige Consumer Healthcare position as of Q2 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 161,749 Prestige Consumer Healthcare shares in Q2 2019, an estimated $4.84M.
  • Loomis, Sayles & Company first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 24 quarters.
  • Loomis, Sayles & Company's Prestige Consumer Healthcare position peaked at $39M in Q2 2015.
  • 212 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2019.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.